Inify Laboratories

Mindre end 1K følgere

INIFY

Euronext Growth Oslo

Medical Equipment & Services

Health Care

Oversigt

Investorkonsensus

Inify Laboratories provides cancer diagnostics through pathology laboratory services. The company uses a digital, standardized workflow for response times and quality assurance, initially in prostate diagnostics. Customers primarily consist of laboratories and hospitals. Inify Laboratories was founded in 2022 and is headquartered in Stockholm, Sweden.

Markedsværdi

-

Aktieomsætning

-

Omsætning

13,5 mio.

EBIT %

-403,58 %

P/E

-

Udbytteafkast, %

-

Finanskalender

25.2

2026

Årsrapport '25

29.4

2026

Delårsrapport Q1'26

20.5

2026

Generalforsamling '26

Alle

Selskabsmeddelelser

ViserAlle indholdstyper

Selskabsmeddelelse30.1.2026, 08.30

Correction: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Selskabsmeddelelse30.1.2026, 08.30

Inify Laboratories AB: Correction: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Selskabsmeddelelse27.1.2026, 17.51

Inify Laboratories - mandatory notification of trade

Inify Laboratories

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto

Følgere og notifikationer om fulgte virksomheder

Analytikerkommentarer og anbefalinger

Værktøj til at sammenligne aktier og andre populære værktøjer

Selskabsmeddelelse27.1.2026, 17.51

Inify Laboratories AB: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Selskabsmeddelelse27.1.2026, 17.46

Inify Laboratories - Final Results of the Repair Issue

Inify Laboratories

Selskabsmeddelelse27.1.2026, 17.46

Inify Laboratories AB: Inify Laboratories - Final Results of the Repair Issue

Inify Laboratories

Selskabsmeddelelse12.1.2026, 07.00

Inify Laboratories - Commencement of subscription period for Repair Issue

Inify Laboratories

Selskabsmeddelelse12.1.2026, 07.00

Inify Laboratories AB: Inify Laboratories - Commencement of subscription period for Repair Issue

Inify Laboratories

Selskabsmeddelelse19.12.2025, 12.25

Inify Laboratories - mandatory notification of trade

Inify Laboratories

Selskabsmeddelelse19.12.2025, 12.24

Inify Laboratories AB: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Selskabsmeddelelse19.12.2025, 12.18

INIFY: Inify Laboratories announces final results of fully guaranteed private placement

Inify Laboratories

Selskabsmeddelelse19.12.2025, 12.18

Inify Laboratories AB: Inify Laboratories announces final results of fully guaranteed private placement

Inify Laboratories

Selskabsmeddelelse17.12.2025, 07.15

Inify Laboratories: Key information regarding Repair Issue

Inify Laboratories

Selskabsmeddelelse17.12.2025, 07.15

Inify Laboratories AB: Inify Laboratories: Key information regarding Repair Issue

Inify Laboratories

Selskabsmeddelelse17.12.2025, 07.00

INIFY: Inify Laboratories announces preliminary results of fully guaranteed private placement

Inify Laboratories

Selskabsmeddelelse17.12.2025, 07.00

Inify Laboratories AB: Inify Laboratories announces preliminary results of fully guaranteed private placement

Inify Laboratories

Selskabsmeddelelse16.12.2025, 13.11

Inify Laboratories - notification of trade

Inify Laboratories

Selskabsmeddelelse16.12.2025, 13.11

Inify Laboratories AB: Inify Laboratories - notification of trade

Inify Laboratories

Selskabsmeddelelse9.12.2025, 07.00

INIFY: Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue

Inify Laboratories

Selskabsmeddelelse9.12.2025, 07.00

Inify Laboratories AB: Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue

Inify Laboratories

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.